2024
Maternal Serotonin Levels and Neurodevelopmental Severity in Autistic Children: A Partial Replication and Extension
Jutla A, Shuffrey L, Guter S, Anderson G, O'Reilly K, Montgomery A, Sutcliffe J, Cook E, Veenstra-VanderWeele J. Maternal Serotonin Levels and Neurodevelopmental Severity in Autistic Children: A Partial Replication and Extension. JAACAP Open 2024 DOI: 10.1016/j.jaacop.2024.09.005.Peer-Reviewed Original ResearchLatent profile analysisSevere profileAdaptive functioningAssociated with social impairmentAutistic childrenAutism symptom severityAutism spectrum disorderNonverbal IQSerotonin systemSocial impairmentAutistic traitsRepetitive behaviorsSerotonin levelsSymptom severityHigh-severity groupSpectrum disorderPartial replicationGroup levelSevere groupExploratory modelProfile analysisChildrenStratified participantsSeveritySerotoninRelationship between maternal serotonin levels and autism-associated genetic variants
Jutla A, Shuffrey L, Guter S, O'Reilly K, Anderson G, Sutcliffe J, Cook E, Veenstra-VanderWeele J. Relationship between maternal serotonin levels and autism-associated genetic variants. Journal Of Clinical Investigation 2024, 134: e179238. PMID: 38963701, PMCID: PMC11364378, DOI: 10.1172/jci179238.Peer-Reviewed Original ResearchLong COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration
Anderson G, Cook E, Blakely R, Sutcliffe J, Veenstra-VanderWeele J. Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration. Journal Of Inflammation Research 2024, 17: 2169-2172. PMID: 38628604, PMCID: PMC11019386, DOI: 10.2147/jir.s456000.Peer-Reviewed Original ResearchPlatelet serotoninSerotonin valuesTrials of SSRIsSerotonin reuptake inhibitorsPlatelet serotonin transportersSerotonin reductionSSRI administrationSSRI treatmentReuptake inhibitorsSerotonin transporterMemory impairmentSerotonin levelsSSRIsSerotoninDepletion of plateletsPlasma serotoninPeripheral serotoninSequelae of COVID-19Viremia patientsCardiovascular sequelaeCirculating serotoninHyperaggregable stateTreatment of COVID-19Clinical trialsLong COVID
2022
Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter
Anderson G, Bruno-Pacella I. Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter. Psychopharmacology 2022, 240: 1-13. PMID: 36399187, DOI: 10.1007/s00213-022-06276-5.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitorsSerotonin transporterPlatelet serotonin transporterSERT occupancyReuptake inhibitorsSystematic reviewClinical implicationsPlatelet serotonin contentMeasurement of plateletPlatelet serotonin uptakePractical clinical implicationsStudy of plateletsSerotonin uptakeHealthy controlsSerotonin contentDifferent SSRIsClinical practicePlateletsInhibitorsUptakeSNRIsSSRIsPatientsReviewTransporters
2021
Primitive Reflexes
de Bildt A, Anderson G, Minderaa R. Primitive Reflexes. 2021, 3672-3673. DOI: 10.1007/978-3-319-91280-6_1560.Peer-Reviewed Original Research
2018
Repint of “Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity”
Tordjman S, Cohen D, Anderson G, Botbol M, Canitano R, Coulon N, Roubertoux P. Repint of “Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity”. Neuroscience & Biobehavioral Reviews 2018, 89: 132-150. PMID: 29391184, DOI: 10.1016/j.neubiorev.2018.01.014.Peer-Reviewed Original ResearchConceptsCognitive-behavioral phenotypeMental disordersAutism spectrum disorderPossible common underlying mechanismNon-categorical approachAutism phenotypeBehavioral syndromeNon-syndromic autismSpectrum disorderDevelopmental trajectoriesAutismSpecific mental disordersCommon underlying mechanismSyndromic autismDiverse genetic disordersEtiological heterogeneityDisordersClinical genetic examinationUnknown disorder
2017
4.12 Maternal Whole Blood Serotonin Levels Predict Verbal Ability and Core Symptoms in Children With Autism Spectrum Disorder
Montgomery A, Shuffrey L, Guter S, Anderson G, Jacob S, Sutcliffe J, Turner J, Cook E, Veenstra-VanderWeele J. 4.12 Maternal Whole Blood Serotonin Levels Predict Verbal Ability and Core Symptoms in Children With Autism Spectrum Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2017, 56: s232. DOI: 10.1016/j.jaac.2017.09.228.Peer-Reviewed Original ResearchReframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity
Tordjman S, Cohen D, Coulon N, Anderson G, Botbol M, Canitano R, Roubertoux P. Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity. Neuroscience & Biobehavioral Reviews 2017, 80: 210. PMID: 28153685, DOI: 10.1016/j.neubiorev.2017.01.030.Peer-Reviewed Original ResearchCognitive-behavioral phenotypeMental disordersAutism spectrum disorderPossible common underlying mechanismNon-categorical approachAutism phenotypeBehavioral syndromeNon-syndromic autismSpectrum disorderDevelopmental trajectoriesAutismSpecific mental disordersCommon underlying mechanismSyndromic autismDiverse genetic disordersEtiological heterogeneityDisordersClinical genetic examinationUnknown disorder
2014
Altered Placental Tryptophan Metabolism: A Crucial Molecular Pathway for the Fetal Programming of Neurodevelopmental Disorders
Bonnin A, Goeden N, Lund B, Anderson G. Altered Placental Tryptophan Metabolism: A Crucial Molecular Pathway for the Fetal Programming of Neurodevelopmental Disorders. 2014 DOI: 10.21236/ada611000.Peer-Reviewed Original ResearchFetal brain developmentFetal programmingMaternal infectionFetal brainMolecular pathwaysMental disordersBrain developmentEssential amino acid tryptophanImpact of inflammationAutism spectrum disorderTrp metabolic pathwayAdult brain functionCrucial molecular pathwaysEarly pregnancyNew molecular pathwaysLong-term consequencesTrp metabolismTrophic factorsTryptophan metabolismAdult offspringPostnatal developmentBrain functionCritical mediatorAmino acid tryptophanNeurodevelopmental disordersHistidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice
Baldan L, Williams K, Gallezot J, Pogorelov V, Rapanelli M, Crowley M, Anderson G, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza K, Ercan-Sencicek A, Krusong K, Leventhal B, Ohtsu H, Bloch M, Hughes Z, Krystal J, Mayes L, de Araujo I, Ding Y, State M, Pittenger C. Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice. Neuron 2014, 82: 1186-1187. DOI: 10.1016/j.neuron.2014.05.023.Peer-Reviewed Original Research
2013
Primitive Reflexes
de Bildt A, Anderson G, Minderaa R. Primitive Reflexes. 2013, 2368-2369. DOI: 10.1007/978-1-4419-1698-3_1560.Peer-Reviewed Original Research
2012
Altered Response to Neuroendocrine Challenge Linked to Indices of the Metabolic Syndrome in Healthy Adults
Tyrka A, Walters O, Price L, Anderson G, Carpenter L. Altered Response to Neuroendocrine Challenge Linked to Indices of the Metabolic Syndrome in Healthy Adults. Hormone And Metabolic Research 2012, 44: 543-549. PMID: 22549400, PMCID: PMC3580172, DOI: 10.1055/s-0032-1306342.Peer-Reviewed Original ResearchConceptsDEX/CRH testBody mass indexHealthy adultsCRH testBlood pressureACTH responseMetabolic syndromeAdrenocorticotropic hormoneDexamethasone/corticotropin-releasing hormone testCorticotropin-releasing hormone testIndices of MetSHPA axis functionNeuroendocrine challenge testsAdrenal axis activityPathogenesis of MetS.Significant medical problemEarly life stressHealthy community sampleCommunity sampleCentral obesityChronic medicationsMetS componentsHDL cholesterolCentral adiposityDevelopment of disease
2010
Pharmacogenetics
Anderson G, Veenstra-VanderWeele J, Cook E, McCracken J. Pharmacogenetics. 2010, 81-91. DOI: 10.1093/med/9780195398212.003.0006.Peer-Reviewed Original ResearchBioanalytical inaccuracy: a threat to the integrity and efficiency of research
Young S, Anderson G. Bioanalytical inaccuracy: a threat to the integrity and efficiency of research. Journal Of Psychiatry And Neuroscience 2010, 35: 3-6. PMID: 20040241, PMCID: PMC2799499, DOI: 10.1503/jpn.090171.Peer-Reviewed Original Research
2008
The potential role for emergence in autism
Anderson GM. The potential role for emergence in autism. Autism Research 2008, 1: 18-30. PMID: 19360647, DOI: 10.1002/aur.2.Peer-Reviewed Original Research
2006
Placental Trophoblast Inclusions in Autism Spectrum Disorder
Anderson GM, Jacobs-Stannard A, Chawarska K, Volkmar FR, Kliman HJ. Placental Trophoblast Inclusions in Autism Spectrum Disorder. Biological Psychiatry 2006, 61: 487-491. PMID: 16806106, DOI: 10.1016/j.biopsych.2006.03.068.Peer-Reviewed Original ResearchEffects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism
Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism. Biological Psychiatry 2006, 61: 545-550. PMID: 16730335, DOI: 10.1016/j.biopsych.2006.02.032.Peer-Reviewed Original ResearchConceptsRisperidone-induced increasesLong-term risperidone treatmentProlactin levelsRisperidone treatmentSerum prolactinOpen-label followWeeks of risperidoneBaseline prolactin levelsEffects of ShortPlacebo groupProlactin elevationReceptor polymorphismsWeek 8Baseline levelsMean increaseProlactinRisperidoneSerum samplesAdverse effectsPlaceboChildrenTreatmentMonthsDRD2 allelesAdolescentsA decrease in the plasma DHEA to cortisol ratio during smoking abstinence predicts relapse
Rasmusson A, Wu R, Paliwal P, Anderson G, Krishnan-Sarin S. A decrease in the plasma DHEA to cortisol ratio during smoking abstinence predicts relapse. Frontiers In Neuroendocrinology 2006, 27: 134. DOI: 10.1016/j.yfrne.2006.03.274.Peer-Reviewed Original Research
2005
Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder
Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biological Psychiatry 2005, 57: 134-138. PMID: 15652871, DOI: 10.1016/j.biopsych.2004.11.003.Peer-Reviewed Original ResearchConceptsAutistic disorderNocturnal urinary excretionPineal gland hormoneLow melatonin productionNormal control individualsMelatonin physiologyGroup of childrenUrinary excretionMelatonin administrationTanner stageSleep problemsNormal controlsReported alterationNocturnal excretionControl individualsExcretion rateDisordersGland hormoneMelatoninMelatonin productionAutistic impairmentsExcretionCircadian rhythmBehavioral expressionVerbal communication
2004
Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey
Anderson GM, Barr CS, Lindell S, Durham AC, Shifrovich I, Higley JD. Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Psychopharmacology 2004, 178: 339-346. PMID: 15452685, DOI: 10.1007/s00213-004-2011-7.Peer-Reviewed Original ResearchConceptsSelective serotonin reuptake inhibitorsCisternal cerebrospinal fluid (CSF) samplesPg/Young adult male rhesus monkeysRhesus monkeysSerotonin reuptake inhibitorsAdult male rhesus monkeysPlasma drug levelsCerebrospinal fluid samplesExtent of elevationMale rhesus monkeysTime courseNon-human primatesAutoreceptor desensitizationSerotonin neurochemistryReuptake inhibitorsNeurochemical effectsResponse latencyProlonged administrationDrug levelsDrug accumulationDay 0SertralineDiscontinuationBaseline